Logo image of KDNY

CHINOOK THERAPEUTICS INC (KDNY) Stock News

NASDAQ:KDNY - Nasdaq - US16961L1061 - Common Stock - Currency: USD

40.39  +0.09 (+0.22%)

After market: 40.32 -0.07 (-0.17%)

KDNY Latest News, Press Relases and Analysis

News Image
2 years ago - The Motley Fool

2 Surging Healthcare Stocks With More Fuel in the Tank

These stocks climbed 74% and 78% over the past month and there could be more gains ahead.

Mentions: VERA

News Image
2 years ago - Chinook Therapeutics, Inc.

Chinook Therapeutics Announces First Patient Enrolled in Pivotal Phase 3 BEYOND Study of Zigakibart (BION-1301) for Patients with IgA Nephropathy

SEATTLE, July 28, 2023 (GLOBE NEWSWIRE) -- Chinook Therapeutics, Inc. (Nasdaq: KDNY), a biopharmaceutical company focused on the discovery, development...

News Image
2 years ago - Pomerantz LLP

SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Chinook Therapeutics, Inc. - KDNY

/PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Chinook Therapeutics, Inc. ("Chinook" or the "Company") (NASDAQ: KDNY). Such...

News Image
2 years ago - Pomerantz LLP

SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Chinook Therapeutics, Inc. - KDNY

/PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Chinook Therapeutics, Inc. ("Chinook" or the "Company") (NASDAQ: KDNY). Such...

News Image
2 years ago - Investor's Business Daily

Meet Chinook Therapeutics, The Company Novartis Is Spending $3.5 Billion To Acquire

Chinook Therapeutics has a history of being opportunistic. Now, it's joining forces with Novartis.

Mentions: NVS ABBV TVTX

News Image
2 years ago - Pomerantz LLP

SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Chinook Therapeutics, Inc. - KDNY

/PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Chinook Therapeutics, Inc. ("Chinook" or the "Company") (NASDAQ: KDNY). Such...

News Image
2 years ago - The Motley Fool

Why Shares of Vera Therapeutics Jumped Tuesday

The company announced early phase 2 trials information regarding its lead therapy.

Mentions: VERA NVS

News Image
2 years ago - Chinook Therapeutics, Inc.

Chinook Therapeutics Presents Data from CHK-336 Phase 1 Trial in Healthy Volunteers and New Insights into the Role of Failed Repair in Chronic Kidney Disease at the 60th European Renal Association (ERA) Congress

CHK-336 was generally well tolerated in healthy volunteers (HV) who received single doses up to 500 mg and multiple doses up to 60 mg for 14...

News Image
2 years ago - Investor's Business Daily

Stock Market Rally Runs Through Hawkish Fed; Adobe, Lennar, Oracle, UnitedHealth In Focus: Weekly Review

Stocks kept powering higher despite, but the Nasdaq is looking extended.

Mentions: LEN ORCL ADBE UNH ...

News Image
2 years ago - Pomerantz LLP

SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Chinook Therapeutics, Inc. - KDNY

/PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Chinook Therapeutics, Inc. ("Chinook" or the "Company") (NASDAQ: KDNY). Such...